CVRx Inc Cash Flow Conversion Efficiency
CVRx Inc cash flow conversion efficiency. Based on the latest financial reports, CVRx Inc (CVRX) has a cash flow conversion efficiency ratio of -0.442x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.83 Million) by net assets ($19.95 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of CVRx Inc (2019–2025)
Cash flow conversion efficiency of CVRx Inc from 2019 to 2025. This chart illustrates how CVRx Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CVRX stock price for real-time trading data and today's change.
CVRx Inc Cash Flow Conversion Ratio Explained
CVRx Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
CVRx Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CVRx Inc ranked by their cash flow conversion efficiency. Also see CVRX company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Calgro M3 Holdings Ltd
JSE:CGR
|
-0.059x |
|
Brill Shoe Industries Ltd
TA:BRIL
|
0.383x |
|
Hanchang Ind.Co.Ltd
KQ:079170
|
0.048x |
|
Baylin Technologies Inc
TO:BYL
|
-0.042x |
|
Southern Fertilizer JSC
VN:SFG
|
0.325x |
|
Cipta Selera Murni Pt
JK:CSMI
|
-0.068x |
|
Frontier Nuclear and Minerals Inc.
NASDAQ:FNUC
|
N/A |
|
ENERSIDE ENERGY EO -01
F:9O8
|
N/A |
Annual Cash Flow Conversion Efficiency for CVRx Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of CVRx Inc from 2019 to 2025. Review CVRx Inc leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $39.32 Million | $-40.17 Million | -1.022x | -85.43% |
| 2024-12-31 | $71.06 Million | $-39.14 Million | -0.551x | -7.22% |
| 2023-12-31 | $75.95 Million | $-39.02 Million | -0.514x | -31.44% |
| 2022-12-31 | $109.18 Million | $-42.68 Million | -0.391x | -105.73% |
| 2021-12-31 | $145.96 Million | $-27.73 Million | -0.190x | -446.14% |
| 2020-12-31 | $-293.24 Million | $-16.10 Million | 0.055x | +19.80% |
| 2019-12-31 | $-279.04 Million | $-12.79 Million | 0.046x | -- |
About CVRx Inc
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased … Read more